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The National Health Insurance (NHI) and social welfare agencies have implemented the Elderly
Health Examination Program (EHEP) for years. No study has ever attempted to evaluate whether
this program is cost-effective. The purposes of this study were, firstly, to understand the prevalence
and incidence rates of hypertension and, secondly, to estimate the cost and effectiveness of the EHEP,
focusing on hypertension screening. The data sources were: (1) hypertension and clinical informa-
tion derived from the 1996 and 1997 EHEP, which was used to generate prevalence and incidence
rates of hypertension; and (2) claim data of the NHI that included treatment costs of stroke
patients (in- and outpatients). Hypothetical models were used to evaluate the cost-effectiveness of
the hypertension screening program in various conditions. Sensitivity analysis was also employed
to evaluate the effect of each estimation indicator on the cost and effectiveness of the hypertension
screening program. A total of 28.3% of the elderly population in Kaohsiung (25,174 of 88,812) partici-
pated in the 1996 EHEP; 14,915 of them participated in the following 1997 EHEP, with a retention rate
of 59.3%. Criteria from the Sixth Report of the Joint National Committee on Detection, Evaluation,
and Treatment of High Blood Pressure (JNC VI) (systolic blood pressure/diastolic blood pressure
≥160/95 mmHg or taking antihypertensive drugs) were used; we found that prevalence and inci-
dence rates of hypertension were 24.6% and 6.6%, respectively. Hypertension rates are increasing in
the aging process as shown in both prevalence and incidence models. In comparison with non-
participants, the prevalence model indicates that each hypertension patient who had attended the
EHEP not only saved NT$34,570–34,890 in medical and associated costs, but also increased their
lifespan by 128 days. The present findings suggest that the EHEP is a cost-effective program with
health and social welfare policy implications. With the relatively low participation rate of the EHEP,
health and social agencies need to put more effort into the promotion of this free health examina-
tion program to attract potential participants. In doing so, the population at risk for hypertension
would be identified for early treatment, and the probability of having stroke could be decreased.
Consequently, health care expenditures for treatment and caregiving of stroke patients would be
minimized. Finally, it should be noted that the sensitivity and values of selected parameters can
modify the results of cost-effectiveness analysis. Interpretations of the effects of prevention services
on costs and effectiveness need to be treated with caution.
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Hypertension is one of the three immediate causes of
stroke. Early detection and appropriate management
of hypertension can prevent the majority of strokes.
Many studies have revealed that a strong relationship
exists between blood pressure and cerebrovascular
disease [1–3]. In addition to the consequence of stroke,
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it can cause other diseases such as heart and renal
diseases that result in long-term morbidity and disabil-
ity [4–7]. The provision of a screening service can detect
the disease at early stages and help to prevent stroke
and other related diseases.
Although hypertension screening is widely rec-
ognized to be an important part of public health policy,
early prevention provides direct savings on medical
costs through reducing health care utilization and
eliminating social and family burden for caregiving
[8]. Studies on the prevalence of hypertension in the
elderly are limited by a smaller sample size [9], or are
sampled in the general population [10–12]. Information
on the incidence of hypertension in elderly persons in
Taiwan is scarce. This paper intends to answer the
following scientific enquiries: (1) to understand the
prevalence and incidence rates of hypertension in eld-
erly persons; (2) to explore the relationship between
aging and change in hypertension rates; and (3) to
estimate the cost-effectiveness of the Elderly Health
Examination Program (EHEP), a public sponsored
massive health screening program in Taiwan.
METHODS
The EHEP and the study population
The EHEP is jointly supported by the Kaohsiung City
Health Department and the Bureau of National Health
Insurance (BNHI), which offer free health examinations
to Taiwanese senior citizens. The program provides a
relatively comprehensive health examination, includ-
ing medical history, physical examination, laboratory
tests, chest X-ray, electrocardiogram, and laboratory
tests [13]. Blood pressure is one of the physiologic
measures of the screening service. Elderly voluntary
participants of the EHEP in 1996 and 1997 were
included in this study.
Estimation of prevalence and incidence
rates of hypertension
Blood pressure was measured by nurses at the four
Kaohsiung City hospitals. Hypertension was defined
according to the criteria of the Sixth Report of the Joint
National Committee on Detection, Evaluation, and
Treatment of High Blood Pressure (JNC VI criteria). 
A patient was confirmed to have hypertension if sys-
tolic blood pressure (SBP) was ≥ 160 mmHg or dias-
tolic blood pressure (DBP) was ≥ 95 mmHg. Elderly
persons who had a medical history of hypertension
or who had taken antihypertensive medication were
also grouped as hypertension cases. To categorize bor-
derline hypertension, the JNC VI criteria (SBP/DBP
≥ 140/90 mmHg or taking antihypertensive drugs)
were used; for the prevalence rate, the 1996 database
was used. As for the incidence rate, a closed cohort
design was used, i.e. elders who attended both the
1996 and 1997 EHEP were included. The normotensive
elderly in 1996 were used to calculate the incidence
rate of hypertension; in other words, subjects with
normal blood pressure in 1996 but who were identi-
fied to have hypertension in 1997 were treated as new
cases of hypertension.
Cost-effectiveness and weighted variables
Cost was measured by the average total costs of 
a stroke case. The direct costs associated with stroke
were mainly derived from the claims data, including
hypertension outpatient treatment costs before stroke
(hospital and clinic visits), hospitalization expenses
of having stroke, and subacute care costs (home care
and/or nursing home expenses) after discharge 
from hospital. The hypertension screening cost was
estimated based on the EHEP cost, which was the
payment for the workload of each blood pressure
measurement.
Effectiveness was measured by average loss of
active life days due to the stroke. The measurement
adopted Weinstein and Stason’s findings [14], i.e. 1.5
quality adjusted life year (QALY) loss after stroke.
Essentially, we aimed to identify how many days 
of active life would be saved for those who attended
the health screening services compared to those who
did not.
The values of parameters important to the model-
ing were mainly derived from anecdotal evidence from
Taiwan population studies [15–17]. For those variables
without any anecdotal evidence from the nation, inter-
national scientific findings were used [6,14,18–21].
Examples are rates of having had stroke for hyper-
tensive patients with or without hypertension treat-
ment, medication compliance rate, and others. Table 1
lists the values and sources of the parameters used in
this study.
Modeling the decision process
Two prediction models were used to estimate the
economic and life impact of the EHEP. One is based
on the prevalence model that uses hypertension preva-
lence rate as the basis of estimation and the other is
based on the incidence prediction model, which adopts
the incidence rate as the basis of prediction. The
Figure illustrates the conceptual model of the study
assumption. Kaohsiung city’s elderly population was
divided into two categories: the EHEP and the non-
EHEP groups. The EHEP group was further catego-
rized into two groups, the same as the non-EHEP
group. Those attending the screening services were
identified as either hypertensive or non-hypertensive.
Fifty percent of the identified cases might seek care for
hypertension and take medication as prescribed by
their doctors. However, half of them may not take any
health care actions at all.
For the non-EHEP group, previous evidence sug-
gested that 43% might go to other institutions for
health screening [17]. Once they have been identified
as hypertensive cases, they seek medical attention
just as those of the EHEP group did. However, about
57% of elders may never get a chance to be identified
as a hypertensive case earlier and receive treatment
as compared to their counterparts.
The probability of suffering a stroke is different
under various conditions. Many assumptions were
made to estimate the costs and life days saved.
Assumption 1 is that EHEP elders who either actively
seek hypertension treatment or not both still have the
probability of suffering a stroke. Assumption 2, the per-
centage of being identified as hypertensive for the
Cost-effectiveness of EHEP
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Table 1. Economic variables: their values and sources
Variable Value/cost (NT$) Range Source
Cost variables
Cost of hypertension treatment 5,436 2,500–7,500 BNHI claims data
(each year)
Total hospitalization cost of stroke 136,077 68,000–204,000 BNHI claims data
patients
Total outpatient cost of stroke patients 53,315 26,700–80,000 BNHI claims data
Hospitalization cost of deceased caused 167,896 84,000–252,000 BNHI claims data
by stroke
Total direct cost of home care 27,984 14,000–42,000 Tseng [15]
(each month)
Total direct cost of nursing home 35,340 18,000–54,000
(each month)
Hypertension screening cost 20 10–30 Estimation from EHEP
Adjusted variables
Incidence rate of stroke with hypertension 0.0151 0.0091–0.0211
treatment (each year)
Incidence rate of stroke without 0.0242 0.0166–0.0318
hypertension treatment (each year) Dahlof et al [6]
Mortality rate of stroke with 0.0017 0.0000–0.0037
hypertension treatment (each year)
Mortality rate of stroke without 0.0071 0.0031–0.0111
hypertension treatment (each year)
Rate of stroke patients requiring 0.203 0.102–0.305
home care Wilkinson et al [18]
Rate of stroke patients requiring 0.087 0.044–0.130
nursing home care
Adjusted variables
Medication compliance rate 0.5 0.25–0.75 Hu et al [16]
Rate of having screening other than 0.43 0.22–0.66 Lin & Kuo [17] 
the program
Adjusted quality of life in stroke 1.5 0–3 Weinstein & Stason [14]
patients (years)
Discount rate (%) 5 0–10 Littenberg et al [19],
Johannesson et al [20],
Jonsson [21]
BNHI = Bureau of National Health Insurance; EHEP = Elderly Health Examination Program.
}
}
non-EHEP group is the same as for the EHEP group.
Assumption 3, those who have not been screened for
hypertension might not know their blood pressure;
consequently, they would not have benefited from
medical attention. The study framework could be
applied to both the prevalence and incidence models.
Sensitivity analysis
Sensitivity analyses were conducted to select appro-
priate values for each parameter used to generate the
cost and effectiveness. Several measurements indi-
cated that a relatively higher sensitivity was carefully
selected. In general, a medium value was adopted 
to avoid bias in the study. Examples are stroke rate
with or without hypertension treatment, mortality
rates for stroke, cost of nursing home and home care,
and so on.
RESULTS
EHEP participation rate and 
retention rate
There were 25,174 and 24,157 of the city’s elderly res-
idents who participated in the 1996 and 1997 EHEP,
representing 28.3% and 26.5% of the total elderly popu-
lation, respectively. Among the 25,174 participants in
1996, 14,915 elders participated in the EHEP in the
following year (1997), with a retention rate of 59.3%. 
Prevalence rate of hypertension
Table 2 indicates three groups—normotension, border-
line hypertension, and hypertension—by age cohort.
In 1996, of 24,266 valid samples, 5,981 or 24.6% were
categorized as having hypertension, 11,730 or 48.3%
of them were normotensive, and 6,555 or 27.0% had
borderline hypertension. For the hypertension group,
the percentage increased with age. For the 65–69
cohort, only 23.8% were classified as hypertensive;
the percentage increased to 26.4% for the age group
75–79, 27.6% for the age group 80–84, and then
jumped to 32.8% for those aged ≥ 85 years. The same
trend could be seen in the borderline group as well,
although there was a relatively lower increase rate
(range, 25.7–29.2%).
Incidence rate of hypertension
For the elders (14,915) with a repeated measure in
1997, 6,942 (46.5%) had been classified as normoten-
sive in 1996. Of 6,942 elders, 461 were identified as
new hypertensive cases, with an incidence rate of 6.6%
(Table 3). More than 20.6% of normotensive patients
were classified into the borderline group. As for the
prevalence group, the incidence rate of hypertension
increased with age. For the age group of 65–69, only
6.1% were identified, then up to 7.9% for the age
group 75–80, and 10.0% for those aged ≥85 years. The
increasing rate was also shown in the borderline
hypertension group (range, 18.7–22.5%).
Cost-effectiveness of EHEP
The estimated total average cost for the treatment 
of EHEP hypertension cases was estimated to be
NT$144,154 for the prevalence model, while for non-
EHEP cases, it was NT$179,044. The EHEP group
saved NT$34,890 compared to the non-EHEP group.
Kaohsiung J Med Sci January 2007 • Vol 23 • No 120
B.H. Deng, H.W. Liu, P.C. Pan, et al
Treatment (50%)
No treatment (50%)
Same as above
No treatment (100%)
EHEP Group
(24,515; 26.5%)
Identified cases
(24.6%)
No screening at all
(57%)
Non-EHEP Group
(68,007; 73.5%)
1997 elderly
population
(92,522) Identified cases
(24.6%)
Screening other than
EHEP (43%)
Figure. Conceptual model based on hypertension prevalence rate.
The effectiveness measure indicated that EHEP hyper-
tension elders might have a loss of 168 active days of
life compared to 296 days for the non-EHEP group. In
other words, elderly persons who participated in the
program might live 128 days longer compared to their
counterparts. The results indicated that participating
in the EHEP can not only save medical and associated
costs (NT$34,890), but also save 128 active days of life
(Table 4). For the incidence model, the estimated total
average cost for the treatment of the EHEP hyperten-
sion cases was NT$144,719, while for non-EHEP cases,
it was NT$179,289. The EHEP group saved NT$34,570
compared to the non-EHEP group. The effectiveness,
or the life days saved, as shown in the incidence model,
was similar to the results of the prevalence model.
Again, the results indicated that participating in the
EHEP not only saved medical and associated costs,
but also saved active days of life.
DISCUSSION
This study finds that preventive health care is cost-
effective. Urban elders who participated in public
Cost-effectiveness of EHEP
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Table 2. Prevalence rates of hypertension by age group in 1996 
n (%)
Age group
Normotension* Borderline hypertension† Hypertension‡
Total
65–69 4,806 (50.5) 2,443 (25.7) 2,261 (23.8) 9,510
70–74 4,358 (48.1) 2,524 (27.9) 2,179 (24.0) 9,061
75–79 1,846 (45.8) 1,117 (27.7) 1,064 (26.4) 4,027
80–84 595 (44.4) 375 (28.0) 369 (27.6) 1,339
≥ 85 125 (38.0) 96 (29.2) 108 (32.8) 329
Total 11,730 (48.3) 6,555 (27.0) 5,981 (24.6) 24,266
*Systolic ≤ 140 and diastolic ≤ 90 mmHg; †140 < systolic < 160 or 90 < diastolic < 95 mmHg; ‡systolic ≥ 160 or diastolic ≥ 95 mmHg.
Table 3. Incidence rate of hypertension by age group in 1996 and 1997
n (%) in 1997
Age group Normotension in 1996
Normotension* Borderline hypertension† Hypertension‡
65–69 2,438 1,833 (75.2) 456 (18.7) 149 (6.1)
70–74 2,908 2,091 (71.9) 630 (21.7) 187 (6.4)
75–79 1,169 822 (70.3) 255 (21.8) 92 (7.9)
80–84 347 248 (71.5) 74 (21.3) 25 (7.2)
≥ 85 80 54 (67.5) 18 (22.5) 8 (10.0)
Total 6,942 5,048 (72.7) 1,433 (20.6) 461 (6.6)
*Systolic ≤ 140 and diastolic ≤ 90 mmHg; †140 < systolic < 160 or 90 < diastolic < 95 mmHg; ‡systolic ≥ 160 or diastolic ≥ 95 mmHg.
Table 4. Cost-effectiveness analysis
Cost-effectiveness EHEP group Non-EHEP group Difference
Prevalence model
Average total costs (NT$) 144,154 179,044 34,890
Loss of life days 168 296 128
Incidence model
Average total costs (NT$) 144,719 179,289 34,570
Loss of life days 168 296 128
EHEP = Elderly Health Examination Program.
health screening services not only lived longer, but
also spent less on medical services, subacute care, and
home care associated with their medical condition.
The prevalence rate of hypertension, identified from
this study, is relatively lower than that of Tseng et al [22]
and Lu et al [9], but is similar to other studies [18,23].
The relatively lower prevalence of hypertension could
partially be explained by the demographic character-
istics of EHEP participants. Older adults who partici-
pate in health screening programs usually tend to be
healthier or have relatively higher degrees of educa-
tion as compared to the general elderly population.
Empirical evidence has shown that education is posi-
tively associated with the elderly’s health status and
information resources [24].
This study was based on a large sample size of the
urban elderly population in southern Taiwan to gen-
erate the incidence of hypertension for Taiwanese eld-
erly persons. The incidence of hypertension as found
in our study sample is similar to findings generated
by other studies [25,26]. However, there is no similar
study based on a nationwide elderly population for
comparison. The present findings provide benchmark
information about the incidence of hypertension in
the elderly population, as well as leading further study
on this subject.
Another important finding of this study was the
revealing of an aging effect on the prevalence and
incidence of hypertension. For both prevalence and
incidence models, the older the participants were, the
higher the prevalence and incidence of hypertension
associated with them. This finding also corresponds
to the results of Yeh et al [11].
The average cost per person and days of life saved
were related to the measures of the cost and effective-
ness, respectively. Both prevalence and incidence
models demonstrated that the preventive screening
program is cost-effective. The magnitude of cost and
days of life saving are similar to previous findings
reported by Johannesson et al [20]. However, the
magnitudes are relatively lower than findings reported
by Littenberg et al [19]. The difference might be
explained by the difference in derived parameters,
time the study was conducted, and the differences in
culture.
It should be noted that the sensitivity and values
of selected parameters can modify the results of cost-
effectiveness analysis. Interpretations of the effects of
prevention services on costs and effectiveness need
to be cautiously made. As with the example of hyper-
tensive patients, the incidence rates of having stroke
with and without treatment were two sensitive para-
meters to costs and effectiveness [19]. On the other
hand, adjusted quality of life and discount rate had a
very low influence on costs and effectiveness. Accord-
ingly, the sensitivity of selected parameters should be
taken into consideration for the evaluation of program
cost-effectiveness.
Furthermore, the values of selected parameters are
also important to the magnitude of program effect on
costs and effectiveness. In order to minimize the bias
of extreme values of parameters, the medium value
of each parameter was used for estimation; however,
the application of the medium might over- or under-
estimate costs for different natures of study samples.
For example, the range for annual costs of hyperten-
sive treatment was NT$2,500–7,500 according to BNHI
data. A medium value of annual costs might be a good
representative of an urban population as in the pres-
ent study; however, it might overestimate the annual
costs of hypertension treatment for rural popula-
tions. For future research, the costs may need to be
adjusted for the degree of urbanization in response to
the socioeconomic status of study samples.
Limitations of the study should be noted. First, all
the participants were volunteers; therefore, the sample
might not be representative of the urban elderly pop-
ulation. Second, several weighting factors were derived
from studies conducted in other countries. These
weightings might not be appropriate for Taiwan. This
reminds us that there is a dearth of valuable infor-
mation in studies of this area. Lastly, since the EHEP is
a massive screening program and hypertension screen-
ing is only one of the many items, the one-time meas-
ure of blood pressure may not be reliable enough.
The study has health policy-making and clinical
implications. Only 28.3% and 26.5% of the elderly
population in Kaohsiung participated in the 1996 and
1997 EHEP, respectively, with a retention rate of 59.3%.
These figures could have two implications, up to 70%
of the urban population did not take up the opportu-
nity for free health screening. Since the program has
proved to be cost-effective, the government should
identify those who failed to participate in the program
and encourage them to participate in health screening.
Only those aged ≥ 65 years qualify for free screening
services. As with the cost-effectiveness evidence of the
EHEP, health policy makers may consider extending
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the eligibility of the EHEP program to younger eld-
erly group(s).
Based on the prevalence and incidence rates, our
estimates indicate that both hypertension and bor-
derline hypertension rates increase with age. The
definition or threshold of hypertension needs to be
adjusted for age in clinical practice. If blood pressure is
a normal aging process, the cut-off point for determin-
ing hypertension should be redefined. Our findings
provide a clinical basis for such preventive services.
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